No Data
No Data
Hims & Hers, LifeMD Shares Soar 20+% Amid Novo Nordisk Deal for Weight-Loss Drugs
Eli Lilly Stock Gets a Double Downgrade. Where Weight-Loss Drugs Go From Here. -- Barrons.com
Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ
ELI LILLY Earnings Preview: Recent $LLY Insider Trading, Hedge Fund Activity, and More
Sector Update: Consumer Stocks Rise in Late Afternoon
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum
frankinglily : High margins and smart reinvestment—sounds like a winning formula. Any risks to watch out for?
Wendyfbe : long on Eli Lilly. But how's their international expansion going?
Lucas Cheah OP frankinglily : The company stands to lose billions annually if Trump’s proposed 25% tariff on pharmaceuticals move forward
Lucas Cheah OP Wendyfbe : the Indian market would be a huge potential with a high demand in drugs like Mounjaro to tackle diabetes and obesity